found that CD2AP was down-regulated and predicted a better prognosis in renal clear cell carcinoma (38), a conclusion consistent with the results of our pan-cancer analysis (CCRCC in Figure 4C, KIRC in Supplementary Figure S2A). The gene discussed is CD2AP; the disease is clear cell renal carcinoma.